Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

55.75p
   
  • Change Today:
      0.40p
  • 52 Week High: 87.40
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 965.19m
  • Volume: 892,220
  • Market Cap: £538.09m

Dr Martens CEO to step down amid bleak profit outlook

By Frank Prenesti

Date: Tuesday 16 Apr 2024

LONDON (ShareCast) - (Sharecast News) - UK bootmaker Dr Martens said chief executive Kenny Wilson has decided to step down as the company issued another profit warning for the current financial year amid continuing woes in the US, its biggest market.
Wilson will be replaced by brand officer Ije Nwokorie before the end of the current financial year, Dr Martens said in a statement.

"There is a wide range of potential outcomes for full-year 2025 given that we have only recently started the year. However, we have assumed that revenue declines by single-digit percentage year-on-year and ... we could see a worst-case scenario of profit-before-tax of around one-third of the 2024 level," it added.

The company issued four profits warnings last year as a tough consumer environment in the US continues to affect sales of its famous boots.

On Tuesday it said USA wholesale revenue was expected to be down by double digits year-on-year, with its autumn/winter order book - which makes up the majority of the second half of US wholesales - forecast to be "significantly" down and hitting profits by £20m.

There would also be a further one-off £35m hit from single-digit cost base inflation and retaining staff.

"As previously communicated, we do not anticipate increasing prices further this year, and therefore in full-year 2025 we are unable to offset cost inflation as we have in prior years," the company said.

"Given the ongoing challenging performance of our US wholesale business, we expect to continue to require the additional inventory storage facilities in this market through 2025, and therefore the majority of the £15m of additional costs incurred in 2024 are expected to repeat."

Reporting by Frank Prenesti for Sharecast.com



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 55.75p
Change Today 0.40p
% Change 0.72 %
52 Week High 87.40
52 Week Low 47.52
Volume 892,220
Shares Issued 965.19m
Market Cap £538.09m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.76% above the market average55.76% above the market average55.76% above the market average55.76% above the market average55.76% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Price Trend
50.59% below the market average50.59% below the market average50.59% below the market average50.59% below the market average50.59% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
56.85% above the market average56.85% above the market average56.85% above the market average56.85% above the market average56.85% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
89.05% below the market average89.05% below the market average89.05% below the market average89.05% below the market average89.05% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 29-Aug-24
Paid 08-Apr-25 01-Oct-24
Amount 0.85p 0.99p

Trades for 09-May-2025

Time Volume / Share Price
16:38 600 @ 55.75p
16:38 1,142 @ 55.75p
16:35 395,698 @ 55.75p
16:35 1 @ 55.75p
16:35 1,225 @ 55.75p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson
CFO Giles Wilson

Top of Page